Genvoya tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FQ2WW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,783
Award facts
- Contract value 100% obligated
- $27,783.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,783.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Genvoya tablets (30-count units) on September 23, 2025, with an ultimate completion date of September 24, 2025. This non-set-aside contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor with an extensive portfolio of brand-name and generic medications across multiple therapeutic domains. The company's Genvoya supply through this delivery order supports the Defense Health Agency and other federal healthcare systems. As a competitively awarded contractor with demonstrated capability in fulfilling federal medical supply requirements, AmerisourceBergen maintains significant relationships with DLA's medical supply chain, delivering specialized pharmaceutical products including antiretroviral treatments, diabetes medications, neurological therapeutics, and medical devices to support military personnel and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FQ2WW?
SPE2DB25FQ2WW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FQ2WW worth?
The government has obligated $27,783 on SPE2DB25FQ2WW.
Is contract SPE2DB25FQ2WW an order under another contract?
Yes. SPE2DB25FQ2WW is a delivery order under SPE2DB22D3011, an indefinite delivery contract.
Was contract SPE2DB25FQ2WW competed?
The extent of competition for SPE2DB25FQ2WW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award